Meet the challenges of today's policy landscape with actionable strategies for igniting and sustaining change. This closing plenary session will examine how advocacy at different levels of the healthcare and prevention continuum can better move in concert together. This plenary session will engage participants in advocacy across HIV, HCV, STIs, Drug User and LGBTQ Health, Immunocompromised Communities, and Health Equity, and closes SYNC 2026 with a clear call to action as we move Forward in SYNChronicity through advocacy.
This special session will: Identify key challenges and political pressures affecting LGBTQ+ health services in California, and examine how healthcare leaders are navigating institutional and regulatory constraints; Analyze real-world strategies and best practices used by health systems and community organizations to protect, sustain, and advance LGBTQ+ affirming care across clinical, educational, and operational settings; and Apply lessons learned from diverse institutional contexts to strengthen participants’ own approaches to advocacy, policy implementation, and adaptive leadership in support of LGBTQ+ health.
Accreditation, Credit, and Support
Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.
Commercial Support Acknowledgement
This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.
POZ
ChemBio
We have received reports that companies are reaching out to sell SYNChronicity Conference attendee lists and other potential services. This is a scam and these companies are not affiliated with SYNChronicity, HealthHIV, HealthHCV, or the National Coalition for LGBTQ Health. Do not engage with them. Please contact us directly with any questions.
